Raise the Line

Even for those with experience in the healthcare system, dealing with health insurance can be confusing and complicated. And for millions of Americans, they have the additional challenge of navigating this complexity in something other than their native language, which is a real barrier to access. Knocking down those barriers is where today’s Raise the Line guest enters the picture. Myong Lee is co-founder and CEO of Clever Care Health Plan, a culturally sensitive Medicare Advantage plan that's tailored to the customs, values and linguistic needs of the diverse communities it serves. The company was sparked by Lee's experience watching his Korean American parents struggle with a system that wasn't designed for them. The mission goes beyond just providing customer service in different languages to including different health customs as well. “My parents certainly have never been to a gym. We saw the opportunity to be able to allow seniors to be able to practice healthcare the way they want to with access to herbal medicine and Tai Chi classes.” Join host Michael Carrese for an exploration of incorporating Eastern and Western medical traditions, assisting seniors in accessing the care they need and deserve and launching a company during a pandemic.Mentioned in this episode: https://clevercarehealthplan.com/ If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Join us for this special episode as we continue a series of conversations with the winners of the Osmosis from Elsevier 2022 Raise the Line Faculty Awards which recognize the inspirational educators who are responsible for training future generations of healthcare professionals. Winners were chosen fromover 1,000 nominations received from 377 institutions around the world. The interviews feature testimonials from the students and peers who nominated the eventual winners focusing on how they embody the six Osmosis core values. Today we feature Michael Moore, the overall winner for the Physician Assistant category. Tapping into his deep passion for education and helping students to succeed, Professor Moore has played an integral role in launching two PA training programs in rural Indiana and Michigan. In his conversation with host Michael Carrese, Moore discusses the growing role of physician assistants on the healthcare team, what he loves about interacting with students, and the need for them to prioritize critical thinking skills. "Something that I think we can work on in even the undergrad years is more critical thinking." From PA education and training to day-to-day responsibilities, you'll gain valuable insights into this critically important and growing profession.Mentioned in this episode: www.osmosis.org/faculty-awards If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

We’re turning the tables on Raise the Line co-host Shiv Gaglani today who will be answering questions, instead of asking them, about Osmosis from Elsevier’s Year of the Zebra campaign.As Shiv explains to host Michael Carrese, he first became interested in rare diseases meeting patients as a medical student at Johns Hopkins University a decade ago. His discomfort with the standard advice given to medical students to think of horses (the common condition) and not zebras (the rare condition) when determining a diagnosis sparked an interest in learning more.  In the ensuing years he created a partnership between Osmosis and NORD, one of the leading rare disease organizations in the world. One result of that relationship is 200 Osmosis educational videos on rare conditions which provide critically needed information to health students, providers and patients.  He has also sought out rare disease patients and parents of children with rare conditions to find out what more could be done to help them. “The more of them I've met, the more inspired I am by their stories and the things they've done as community organizers, researchers, scientists, advocates and policy changemakers.” Don’t miss this lively conversation about the components of the campaign - including Elsevier’s new open access journal on rare diseases - and how you can get involved. And, you won’t want to miss Shiv’s recounting of his climb of Mt. Kilimanjaro to raise money for the campaign, including the special photo taken at the summit.    Mentioned in this episode: www.osmosis.org/zebra If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Join us on this special episode as we continue a series of conversations with the winners of the Osmosis from Elsevier 2022 Raise the Line Faculty Awards which recognize the inspirational educators who are responsible for training future generations of healthcare professionals. Winners were chosen fromover 1,000 nominations received from 377 institutions around the world. The interviews feature testimonials from the students and peers who nominated the eventual winners focusing on how they embody the six Osmosis core values. On today’s episode, hostLindsey Smith speaks with Dr. Joanne Baxter, the first female dean of Dunedin School of Medicine at the University of Ōtākou in 148 years. As a champion of diversity, equity, and inclusion, Dr. Baxter discusses the importance of DEI in both the medical field and society at large. Drawing from her Māori heritage, she emphasizes the significance of collaborating with marginalized communities to ensure equitable healthcare access. Through her conversation with Lindsey, she explains the importance of understanding the roots of inequality and highlights how the younger generations are leading the way. “This next generation really embraces and engages with conversations about equity and diversity in a way that is much more open and progressive.” Mentioned in this episode: www.osmosis.org/faculty-awards If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

One of our favorite themes on Raise the Line is how technology can help people become better informed about their own health, allowing them to participate more actively in maintaining and improving it. Well, today, we're going to take a deeper look at that issue with the help of Carol Lucarelli, Executive Director of Marketing and E-Commerce at Omron Healthcare, the global leader in remote blood pressure monitoring and personal health technology. “We want individuals to take responsibility for understanding what ails them and be part of the care plan to get better.” The medical devices Omron makes can help do that by providing patients and their providers with timely data from remote monitors of various types.  One of the most common is blood pressure monitors, which Lucarelli says could go a long way in preventing strokes and heart attacks if used diligently.  And it stands to reason that if providers are on top of changes in key health measurements taken at home, they can catch problems early lessening the need for trips to the doctor’s office or emergency room. Join host Michael Carrese for an informative look at the current role of remote monitoring, what’s coming down the road and how medical devices can help facilitate a dialogue between providers and patients. Mentioned in this episode: https://omronhealthcare.com/ If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

How will the healthcare system navigate unprecedented workforce and financial challenges? What can be done about staff and leader burnout? How can healthcare systems increase diversity and equity? These are the types of big picture questions Deborah Bowen and her colleagues confront at the American College of Healthcare Executives, an international society of more than 48,000 executives in hospitals, healthcare systems and other healthcare organizations. After nearly three decades with the organization, Bowen has a deeply informed take on the kinds of support leaders need in motivating teams to realize their vision. But she is also quick to point out that change in healthcare is not just about who is sitting in the C-suite. “What I love most about healthcare is there are very influential people all throughout the organization. I think anybody who really has the intention to be a leader can be a leader,” she tells host Shiv Gaglani. Don’t miss this chance to hear from someone who has been named one of the most influential people in healthcare about COVID’s impact, why she’s excited about the future of the field and what emerging healthcare professionals can do to change the system.Mentioned in this episode: https://www.ache.org/ If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Join us on this special episode as we start a series of conversations with the winners of the Osmosis from Elsevier 2022 Raise the Line Faculty Awards which recognize the inspirational educators who are responsible for training future generations of healthcare professionals. Winners were chosen fromover 1,000 nominations received from 377 institutions around the world.  The interviews feature testimonials from the students and peers who nominated the eventual winners focusing on how they embody the six Osmosis core values.  We start with Dr. Athanasios Hassoulas, Director of the Master of Science Psychiatry Program and Digital Education Lead at Cardiff University in Wales who won the “Other Health Professionals” category. Dr. Hassoulas tells host Michael Carrese about how his teaching innovations are informed by students and about the challenges and opportunities of incorporating digital technology into teaching practices. Dr. Hassoulas also shares how his personal experience with OCD led him to pursue a career in psychiatry and inspires his teaching philosophy. "I think care is the philosophy that underpins what I do.”  Don't miss this insightful conversation with a remarkable educator who is breaking down barriers and raising the bar for excellence in medical education.Mentioned in this episode: www.osmosis.org/faculty-awards If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Regular listeners to Raise the Line know that research into rare diseases should matter to everybody because it has led to treatments for much more common conditions that have improved and saved millions of lives. Statins are usually the prime example of that. Well, on this episode we're going to get into much more detail on this point with someone who literally wrote the book on the subject: Dr. Jules Berman. His 2014 work published by Elsevier, Rare Diseases and Orphan Drugs, Keys to Understanding and Treating the Common Diseases, shows that much of what we now know about common diseases has been achieved by studying rare diseases, and therefore, accelerating progress in the field of rare diseases will lead to yet more advances affecting common conditions. “If you have a rare disease and you think about the phenotype that results from it, you can often find that same phenotype occurring much more commonly in acquired disease, so the treatment for the rare disease can often help people with the acquired disease.” Don’t miss this provocative conversation with host Michael Carrese as Dr. Berman shares why he thinks researching one rare disease at a time is a flawed approach, especially in light of his belief that there are more than 50,000 rare conditions.  If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Lucy Landman is one of only a few children known worldwide to have a genetic disorder called PGAP3, in which a single missing gene can cause seizures and severe physical and cognitive limitations. Luckily for Lucy, her parents Geri and Zach Landman are both physicians whose expertise has been a big help in obtaining a diagnosis and in advocating for her. The Landmans are bringing that know-how and a fervent desire to help all children with single gene disorders to the non-profit they founded, Moonshots for Unicorns, which is already working with Nationwide Children’s Hospital on a promising gene therapy.  “There are so many of these single gene disorders that should be amenable to things like gene therapy and drug repurposing. So, we don't want this just to focus on PGAP3.” Listen to this moving episode with host Michael Carrese to learn what causes PGAP3, how the rare genetic disorder has impacted Lucy’s life and health, and the suspected connection between PGAP3 and Autism. Dr. Landman also addresses the big gaps she sees in newborn screening, medical education and research efforts from a rare disease perspective.Mentioned in this episode: www.moonshotsforunicorns.org If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

Eighty percent of rare diseases are caused by genetic mutations, which is why many of our recent guests have highlighted the importance of pursuing gene therapies as potential treatments and cures. That’s why we’re particularly pleased to have Dr. Gaurav Shah on Raise the Line today. He’s the CEO of Rocket Pharma, a company that’s in hot pursuit of developing curative gene therapies for patients with inherited genetic diseases, and showing remarkable results in some cases. For instance, a gene therapy for a rare and fatal heart condition called Danon disease is moving every parameter in the right direction, a result Dr. Shah is understandably proud of. “When gene therapy works, it really works. We were able to demonstrate the power of gene therapy for heart disease for the first time in our species,” he tells host Michael Carrese. Don’t miss this fascinating look at the art, science and practicalities of developing gene therapies and where Rocket Pharma is seeing progress. You’ll also learn about the many career options in drug development and hear how Dr. Shah’s background as a Grammy-winning artist informs his approach to leadership.Mentioned in this episode: https://rocketpharma.com/ If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast